See also this year's filing and all EDGAR filings for this company.
PDF Report 0001159019_2014_Tribute_Pharmaceuticals_Canada_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossFromContinuingOperations'} |
Graph
Absolute values for 0001159019, Tribute Pharmaceuticals Canada Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,374,660 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 13,316,250 |
| 2 | PropertyPlantAndEquipmentNet | 1,089,919 |
| 3 | remainder_Assets | 253,712 |
| 4 | LiabilitiesCurrent | 6,494,326 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 5,640,102 |
| 7 | CostOfGoodsAndServicesSold | 1,541,662 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,830,132 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 7,147,275 |
| 11 | remainder_Revenues | 13,440,361 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -1,493,647 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 20,034,541 |
| 1 | Liabilities | 12,134,428 |
| 2 | Expenses | 18,519,069 |
| 3 | Revenues | 13,440,361 |
| 4 | StockholdersEquity | 7,900,113 |
| 5 | NetIncome | -5,078,708 |
| 6 | ComprehensiveNetIncome | -5,825,532 |
| 7 | BaseVar | 32,811,023 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.709 |
| 9 | EconomicCapitalRatio | 2.06 |
Edgar->Model Mapping
Feature Distribution
Change over Time
